SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Techniclone (TCLN) -- Ignore unavailable to you. Want to Upgrade?


To: shero who wrote (2598)10/5/1998 8:37:00 PM
From: john dixon  Read Replies (1) | Respond to of 3702
 
Shero. very good post. You are so right in that the only thing that matters now are results from the trials. As you know I have been in tcln 8 plus years now. I have to admit, today when we hit .97 I said to myself, the hell with it, but I can't let go, we are to close. I don't trust mgt, I don't like what has happened in the past, but that's all it is, the past, gone, over with, we can not change it. I am staying because, 1. I want this to be the best investment that I have ever made and more important 2, TNT does work and I want to be a part of that.

john

PS: Bymaster, I hope you read this post. What you have been given is the chance of a lifetime, please, please, take advantage of it.



To: shero who wrote (2598)10/7/1998 4:23:00 PM
From: Maurice Winn  Respond to of 3702
 
Shero, just a guess, but maybe the results on Oncolym just take a while to get prepared and there is little to say. In the absence of a licence announcement, there probably wasn't an agreement. But as you say, maybe Legere got it - not likely though. What would he want it for? He can't do much with it other than trade it.

Meanwhile, all the raving over the repriced stock options is becoming a bit irrelevant. As was allegedly said, by the meeting, nobody would be worried about the repriced options. Well, with the share price nearing the repriced option price, I guess people won't really be worried about the repricing will they? They can now buy at about the same price themselves, without having to serve on the board or perform other corporate functions.

All the market is down, so I guess TCLN is tagging along for the ride.

Maurice